Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.
暂无分享,去创建一个
Zhiqin Ji | Irini Akritopoulou-Zanze | K. Glaser | S. Davidsen | P. Hajduk | J. R. Huth | D. Song | Eric F. Johnson | N. Soni | C. Abad-Zapatero | I. Akritopoulou‐Zanze | M. Michaelides | P. Marcotte | Z. Ji | L. Pease | K. Stewart | Philip J Hajduk | Stevan W Djuric | V. Gracias | S. Djurić | Cele Abad-Zapatero | Vijaya Gracias | Eric F Johnson | Jeffrey R Huth | Danying Song | Keith B Glaser | Patrick A Marcotte | Lori Pease | Nirupama B Soni | Kent D Stewart | Steven K Davidsen | Michael R Michaelides
[1] S. Davidsen,et al. 1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors. , 2006, Bioorganic & Medicinal Chemistry Letters.
[2] H. Gelderblom,et al. Small Molecule Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: An Update of Recent Developments , 2007, Annals of Surgical Oncology.
[3] K. Glaser,et al. Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors. , 2005, Journal of medicinal chemistry.
[4] M. Malumbres,et al. Targeting cell cycle kinases for cancer therapy. , 2007, Current medicinal chemistry.
[5] Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases. , 2006, Bioorganic & medicinal chemistry letters.
[6] J. R. Huth,et al. Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors. , 2006, Bioorganic & medicinal chemistry letters.
[7] P. Richardson,et al. Pseudosubstrate peptides inhibit Akt and induce cell growth inhibition. , 2004, Biochemistry.
[8] K. Glaser,et al. Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. , 2007, Journal of medicinal chemistry.
[9] S. Schenone,et al. Antiangiogenic agents: an update on small molecule VEGFR inhibitors. , 2007, Current medicinal chemistry.
[10] Jeffrey Jie-Lou Liao,et al. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. , 2007, Journal of medicinal chemistry.